Riverwoods, IL, United States of America

Susan E Lappe

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 9.1

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Susan E. Lappe

Introduction

Susan E. Lappe is a prominent inventor located in Riverwoods, IL, who has made significant contributions to the field of biomedical innovation. With a total of four patents to her name, Susan has focused her research on developing groundbreaking therapeutic proteins aimed at combating cancers and other angiogenesis-dependent diseases.

Latest Patents

Susan's latest patents reflect her commitment to advancing medical treatments. One of her notable inventions is the "Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof." This patent involves multivalent and multispecific binding proteins that are essential for the diagnosis, monitoring, inhibition, prevention, and treatment of cancers and tumors linked to aberrant DLL4 and VEGF activity. Additionally, she holds a patent for "Single-chain TRAIL-receptor agonist proteins," which includes specific TRAIL receptor agonist proteins and nucleic acids designed for treating TRAIL-associated diseases. These proteins are designed to be substantially non-aggregating, making them suitable for various therapeutic, diagnostic, and research applications.

Career Highlights

Throughout her career, Susan has been associated with renowned companies such as AbbVie Inc. and Apogenix AG, where she has contributed her expertise in the development of novel therapeutic solutions. Her work has positioned her as a leader in the field of immunotherapy and cancer treatment, paving the way for advancements in modern medicine.

Collaborations

Susan has collaborated with talented professionals in her field, including Jijie Gu and Dominic J. Ambrosi. These collaborations have enriched her research and expanded the impact of her innovations within the scientific community. By working alongside esteemed colleagues, Susan has maximized the potential for her inventions to translate into viable medical solutions.

Conclusion

Susan E. Lappe's innovative spirit and dedication to her field have resulted in several critical advancements in cancer treatment and research. Her patents not only exemplify her creative capabilities as an inventor but also highlight her commitment to improving patient outcomes through science and technology. As she continues to develop new solutions, Susan remains an inspiring figure in the realm of biomedical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…